Day: June 30, 2025

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathyTwo phase 3 studies are currently underway testing riliprubart in people with CIDP as a potential first-in-class treatment Japanese Ministry of Health, Labour and Welfare decision adds to similar designations in the US and Europe, underscoring global regulatory recognition of the potential for riliprupart to address significant unmet medical needs for people living with this rare neurological conditionParis, June 30, 2025. The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted orphan drug designation to riliprubart, a monoclonal antibody that selectively inhibits activated C1s in the classical complement pathway for people with chronic inflammatory demyelinating polyneuropathy (CIDP). Despite available therapies,...

GUANGZHOU, China, June 29, 2025 (GLOBE NEWSWIRE) — Last Friday, Singapore’s Acting Minister for Transport, Mr. Jeffrey Siow, led a high-level delegation to WeRide’s (Nasdaq: WRD) headquarters in Guangzhou, underscoring growing cooperation between the Ministry of Transport (MOT) and WeRide to advance autonomous mobility and strengthen Singapore’s public transport system. Accompanying Acting Minister Siow were Senior Minister of State for Transport Sun Xueling; leaders from the National Transport Workers Union, National Taxi Association, and National Private Hire Vehicles Association; as well as representatives from the MOT and the Land Transport Authority (LTA). The delegation was welcomed by Tony Han, Founder and CEO of WeRide; Jennifer Li, CFO and Head of International of WeRide; Kerry Xu, General Manager of...